Table 3.
Serum ALP (nmol/60 min) | Serum PINP (ng/mL) | Serum OC (ng/mL) | Serum TRAP (U/L) | TRAP+ cells (%) | |
---|---|---|---|---|---|
Group 1 | 1.54±0.08 | 2.41±0.30 | 73.02±10.64 | 10.66±4.28 | 18.67±1.65 |
Group 2 | 0.87a±0.04 | 2.19±0.38 | 125.3b±11.41 | 210.8a±42.67 | 79.80a±8.53 |
Group 3 | 0.99±0.08 | 3.24±0.76 | 133.6±18.8 | 173.3±31.71 | 59.33±4.75 |
Group 4 | 1.23c±0.11 | 4.40d,e±0.85 | 78.98d±14.90 | 136.7±23.80 | 26.69f±2.95 |
Group 5 | 1.00±0.11 | 2.47±0.29 | 84.28±6.92 | 188.3±11.56 | 67.50±8.37 |
Notes: Group 1: normal control; group 2: CAIA control; group 3: CH-DEAE15/siRNA-TNFα–treated mice; group 4: folate-PEG-CH-DEAE15/siRNA-TNFα–treated mice; group 5: siRNA-TNFα–treated mice. The data are expressed as means ± SEM. Groups 1–4: eight mice each; group 5: five mice.
P<0.001 compared to normal mice.
P<0.01 compared to normal mice.
P<0.01 compared to CAIA mice.
P<0.05 compared to CAIA mice.
P<0.05 compared to normal mice.
P<0.001 compared to CAIA mice.
Abbreviations: ALP, alkaline phosphatase; CAIA, collagen antibody-induced arthritis; CH, chitosan; DEAE, diethylethylamine; OC, osteocalcin; PEG, polyethylene glycol; PINP, procollagen I N-terminal peptide; SEM, standard error of the means; TNFα, tumor necrosis factor-alpha; TRAP, tartrate-resistant acid phosphatase.